{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:44:00Z","timestamp":1773215040196,"version":"3.50.1"},"reference-count":34,"publisher":"Gobierno de Navarra","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An Sist Sanit Navar"],"published-print":{"date-parts":[[2009,4,23]]},"DOI":"10.23938\/assn.0398","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T08:55:24Z","timestamp":1547110524000},"page":"283-299","source":"Crossref","is-referenced-by-count":0,"title":["Candidiasis secondary to antibiotic treatment in primary care"],"prefix":"10.23938","volume":"24","member":"10024","reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0002-9378(98)80001-X","article-title":"Vulvovaginal candidiasis: epidemiologic, diagnostic and therapeutic considerations","volume":"178","author":"SOBEL","year":"1998","unstructured":"1. SOBEL JD, FARO S, FORCE RW, FOXMAN B, LEDGER WJ, NYIRJESY PR, REED BD, SUMMERS PR. Vulvovaginal candidiasis: epidemiologic, diagnostic and therapeutic considerations. Am J Obstet Gynecol 1998; 178: 203-211.","journal-title":"Am J Obstet Gynecol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/clinids\/14.Supplement_1.S148","article-title":"Pathogenesis and treatment of recurrent vulvovaginal candidiasis","volume":"14","author":"SOBEL","year":"1992","unstructured":"2. SOBEL JD. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin Infect Dis 1992; 14: 148-153.","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/j.1552-4604.1992.tb03833.x","article-title":"Evolving pathogens in vulvovaginal candidiasis: implications for patient care","volume":"32","author":"BJ","year":"1992","unstructured":"3. HOROWITZ BJ, GIAQUINTA D. Evolving pathogens in vulvovaginal candidiasis: implications for patient care. J Clin Pharmacol 1992; 32: 248-255.","journal-title":"J Clin Pharmacol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/0278-2391(91)90066-U","article-title":"Diagnosis and treatment of oral candidosis","volume":"49","author":"LEWIS","year":"1991","unstructured":"4. LEWIS MAO, SAMARANYAKE LP, LAMEY J. Diagnosis and treatment of oral candidosis. J Oral Maxillofac Surg 1991; 49: 996-1002.","journal-title":"J Oral Maxillofac Surg"},{"key":"ref4","unstructured":"5. DREIZEN S. Oral candidiasis. Am J Med 1984; 77: 28-33."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S1081-1206(10)63024-4","article-title":"Esophageal candidiasis as a complication of inhaled corticosteroids","volume":"79","author":"SIMON","year":"1997","unstructured":"6. SIMON MR, HOUSER WL, SMITH KA, LONG PM. Esophageal candidiasis as a complication of inhaled corticosteroids. Ann Allergy Asthma Immunol 1997; 79: 333-338.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1128\/iai.44.3.702-707.1984","article-title":"Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans","volume":"44","author":"POLLOCK","year":"1984","unstructured":"7. POLLOCK JJ, DENEPITIYA L, MACKAY BJ, IACONO VJ. Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans. Infect Inmun 1984; 44: 702-707.","journal-title":"Infect Inmun"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/0140-6736(91)91296-7","article-title":"Role of Candida in pathogenesis of antibioticassociated diarrhoea in elderly in patients","volume":"337","author":"DANNA","year":"1991","unstructured":"8. DANNA PL, URBAN C, BELLIN E, RAHAL JJ. Role of Candida in pathogenesis of antibioticassociated diarrhoea in elderly in patients. Lancet 1991; 337: 511-514.","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.14219\/jada.archive.1992.0010","article-title":"Diagnosing and managing oral candidiasis","volume":"123","author":"ALLEN","year":"1992","unstructured":"9. ALLEN CM. Diagnosing and managing oral candidiasis. J Am Dent Assoc 1992; 123: 77-82.","journal-title":"J Am Dent Assoc"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0149-2918(98)80033-7","article-title":"Oropharingeal candidiasis: a reviex of its clinical spectrum and current therapies","volume":"20","author":"JB","year":"1998","unstructured":"10. EPSTEIN JB, POLSKY B. Oropharingeal candidiasis: a reviex of its clinical spectrum and current therapies. Clin Ther 1998; 20: 40-57.","journal-title":"Clin Ther"},{"key":"ref10","unstructured":"11.WALKER DM, ARENDORF T. Candidal leukoplakia, chronic multifocal candidiasis and median rhomboid glossitis. Samaranyake LP, Macfarlane TW (eds): in oral candidiasis, Bristol, Wright, 1990, 184- 199."},{"key":"ref11","unstructured":"12. KRETZSCHUZAR JL, KRETZSCHMAR DP. Courmon oral conditions. Am Fam Physician 1996; 54: 225-234."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"633","DOI":"10.2165\/00003495-198836050-00006","article-title":"Candidosis of the oral cavity: recognition and management","volume":"36","author":"HAY","year":"1988","unstructured":"13. HAY KD. Candidosis of the oral cavity: recognition and management. Drugs 1988;36: 633-642.","journal-title":"Drugs"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/00325481.1989.11700671","article-title":"Oral and pharingeal candidiasis: topical agents for management and prevention","volume":"85","author":"EPSTEIN","year":"1989","unstructured":"14. EPSTEIN JB. Oral and pharingeal candidiasis: topical agents for management and prevention. Postgrad Med 1989; 85: 257-269.","journal-title":"Postgrad Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1079-2104(96)80219-8","article-title":"Oral pathoses caused by Candida albicans during chemotherapy: update on development mechanisms","volume":"82","author":"BUNETEL","year":"1996","unstructured":"15. BUNETEL L, BOURAURE-MALLET M. Oral pathoses caused by Candida albicans during chemotherapy: update on development mechanisms. Oral Surg Oral Med Oral Pathol 1996; 82: 161-165.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16.Working group of the british society for medical mycology. Management of genital candidiasis. Br Med J 1995; 310: 1241-1244.","DOI":"10.1136\/bmj.310.6989.1241"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1136\/bmj.1.6176.1450","article-title":"Vaginal microbial flora in normal young women","volume":"1","author":"GOLDACRE","year":"1979","unstructured":"17. GOLDACRE MJ, WATT B, LONDON N, MILNE LJR, LONDON JD, VESSEY MP. Vaginal microbial flora in normal young women. Br Med J 1979; 1: 1450-1455.","journal-title":"Br Med J"},{"key":"ref17","unstructured":"18. GARC\u00cdA JF, SCHENEIDER J, PONT\u00d3N J. Vulvovaginitis candidi\u00e1sica. Med Cl\u00edn (Barc) 1994; 103: 505-508."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/00003081-199303000-00016","article-title":"Vaginal flora in health and disease","volume":"36","author":"LARSEN","year":"1993","unstructured":"19. LARSEN B. Vaginal flora in health and disease. Clin Obstetr Gynecol 1993; 36: 107-121.","journal-title":"Clin Obstetr Gynecol"},{"key":"ref19","unstructured":"20. HEDDERWICK S, KAUFFMAN CA. Opportunistic fungal infections: superficial and systemic candidiasis. Geriatrics 1997; 52: 50-59."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1471-0528.1975.tb00599.x","article-title":"Vaginal candidiasis and the role of the digestive tract as a source of infection","volume":"82","author":"AL","year":"1975","unstructured":"21. HILTON AL, WARNOCK DW. Vaginal candidiasis and the role of the digestive tract as a source of infection. Br J Obstet Gynaecol 1975; 82: 922-926.","journal-title":"Br J Obstet Gynaecol"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. FOX KK, BEHETS FMT. Vaginal discharge: how to pintpoint the cause. Postgrad Med 1995; 96: 87-104.","DOI":"10.1080\/00325481.1995.11946044"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. DOUGALL HT, SMITH L, DUNCAN C, BENJAMIN N. The effect of amoxycillin on salivary nitrite concentrations: an important mechanism of adverse reactions? Br J Clin Pharmac 1995; 39: 460-462.","DOI":"10.1111\/j.1365-2125.1995.tb04479.x"},{"key":"ref23","unstructured":"24.MAC DONALD TM, BEARDON PHG, MCGILCHRIST MM, DURCAN ID, MCKENDRICK AD, MC DEVITT. The risks of symptomatic vaginal candidiasis after oral antibiotic therapy. Q J Med 1993; 86: 419-424."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/00003081-199303000-00021","article-title":"Candidal vulvovaginitis","volume":"36","author":"SOBEL","year":"1993","unstructured":"25. SOBEL JD. Candidal vulvovaginitis. Clin Obstetr Gynecol 1993; 36: 153-165.","journal-title":"Clin Obstetr Gynecol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/0029-7844(96)00123-8","article-title":"Recurrent vulvovaginal candidiasis associated with long-term tamoxifen treatment in postmenopausal women","volume":"88","author":"SOBEL","year":"1996","unstructured":"26. SOBEL JD, CHAIM W, LEAMAN D. Recurrent vulvovaginal candidiasis associated with long-term tamoxifen treatment in postmenopausal women. Obstet Gynaecol 1996; 88: 704-706.","journal-title":"Obstet Gynaecol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1001\/archderm.1995.01690200105029","article-title":"Omeprazole as a cause of oral candidiasis","volume":"131","author":"ANDERSON","year":"1995","unstructured":"27. ANDERSON PC. Omeprazole as a cause of oral candidiasis. Arch Dermatol 1995; 131: 965-","journal-title":"Arch Dermatol"},{"key":"ref27","unstructured":"966."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1002\/1097-0142(19821215)50:12<2780::AID-CNCR2820501215>3.0.CO;2-P","article-title":"C\u00e1ndida infections in patients with acute leukemia: infecctiveness on nystatin prophylaxis and relationship between oropharyngeal and sistemic candidasis","volume":"50","author":"DE GREGORIO","year":"1982","unstructured":"28. DE GREGORIO MW, LEE WMF, RIES CA. C\u00e1ndida infections in patients with acute leukemia: infecctiveness on nystatin prophylaxis and relationship between oropharyngeal and sistemic candidasis. Cancer 1982; 50: 2780-2784.","journal-title":"Cancer"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1001\/archinte.1987.00370040092016","article-title":"A prospective, randomized, controlled, double-blind study","volume":"147","author":"HANSEN","year":"1987","unstructured":"29. HANSEN RM, REINERIO N, SOHNLE PG, ABRAMS RA, RITCH PS, LIBNOCH JA et al. Ketoconazole in the prevention of candidiasis in patients with cancer. A prospective, randomized, controlled, double-blind study. Arch Intern Med 1987; 147: 710-712.","journal-title":"Arch Intern Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/clinids\/9.2.408","article-title":"Prevention of mycosis in immunocompromised patients","volume":"9","author":"MEUNIER","year":"1987","unstructured":"30.MEUNIER F. Prevention of mycosis in immunocompromised patients. Rev Infect Dis 1987; 9: 408-416.","journal-title":"Rev Infect Dis"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1001\/archsurg.1987.01400140029002","article-title":"Ketoconazole prevents C\u00e1ndida sepsis in critically ill surgical patients","volume":"122","author":"GJ","year":"1987","unstructured":"31. SLOTMAN GJ, BURCHARD KW. Ketoconazole prevents C\u00e1ndida sepsis in critically ill surgical patients. Arch Surg 1987; 122: 147-151.","journal-title":"Arch Surg"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplatation","volume":"326","author":"GOODMAN","year":"1992","unstructured":"32. GOODMAN JL, WINSTON DJ, GREENFIELD RA, CHANDRASEKAR PH, FOX B, KAIZER H et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplatation. N Engl J Med 1992; 326: 845-851.","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"33.WINGARD JR, MERZ WG, RINLADI MG, JOHNSON TR, KARP JE, SARAL R. Increase in C\u00e1ndida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 1274-1277.","DOI":"10.1056\/NEJM199110313251803"}],"container-title":["Anales del Sistema Sanitario de Navarra"],"original-title":[],"link":[{"URL":"https:\/\/recyt.fecyt.es\/index.php\/ASSN\/article\/view\/5971\/4812","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T09:49:17Z","timestamp":1773136157000},"score":1,"resource":{"primary":{"URL":"https:\/\/recyt.fecyt.es\/index.php\/ASSN\/article\/view\/5971\/4812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,23]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,4]]}},"URL":"https:\/\/doi.org\/10.23938\/assn.0398","relation":{},"ISSN":["1137-6627"],"issn-type":[{"value":"1137-6627","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4,23]]}}}